HemaSphere
(Jun 2022)
P657: REAL-WORLD TREATMENT PATTERNS OF PATIENTS DIAGNOSED WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IN THE UNITED STATES (US)
- X. Yang,
- E. Zanardo,
- D. Lejeune,
- E. De Nigris,
- E. Sarpong,
- N. Lema,
- M. Farooqui,
- F. Laliberté
Affiliations
- X. Yang
- 1 Merck & Co., Inc., Kenilworth
- E. Zanardo
- 2 Analysis Group, Inc., Boston, United States of America
- D. Lejeune
- 3 Groupe d’analyse, Ltée, Montréal, Canada
- E. De Nigris
- 1 Merck & Co., Inc., Kenilworth
- E. Sarpong
- 1 Merck & Co., Inc., Kenilworth
- N. Lema
- 2 Analysis Group, Inc., Boston, United States of America
- M. Farooqui
- 1 Merck & Co., Inc., Kenilworth
- F. Laliberté
- 3 Groupe d’analyse, Ltée, Montréal, Canada
- DOI
-
https://doi.org/10.1097/01.HS9.0000845512.90056.65
- Journal volume & issue
-
Vol. 6
pp.
555
– 556
WeChat QR code